Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction

The Epstein-Barr virus (EBV) infects more than 95% of adults worldwide and is associated with various malignant tumors and immune diseases, imparting a huge disease burden on the human population. Available EBV vaccines are imminent. Prophylactic vaccines can effectively prevent the spread of infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Jing, Zhang, Bodou, Li, Yuqi, Zhu, Wanfang, Akihisa, Toshihiro, Li, Wei, Kikuchi, Takashi, Liu, Wenyuan, Feng, Feng, Zhang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623587/
https://www.ncbi.nlm.nih.gov/pubmed/34835222
http://dx.doi.org/10.3390/vaccines9111290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623587/
https://www.ncbi.nlm.nih.gov/pubmed/34835222
http://dx.doi.org/10.3390/vaccines9111290

Ejemplares similares